levothyroxine / liothyronine Oral Product

RxCUI
1602751
RxNorm name
levothyroxine / liothyronine Oral Product
Term type
SCDG
Status
Active
Updated
2026-11-02 22:13:56

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032015
Active start
032015
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582
liothyronine10814

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRlevothyroxine / liothyronine Oral Product1NAMES
RxNorm Namelevothyroxine / liothyronine Oral Product1NAMES
TTYSCDG1ATTRIBUTES
RxCUI16027511CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH03AAThyroid hormonesATC1-4levothyroxine sodium
ATCH03AAThyroid hormonesATC1-4liothyronine sodium
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLD014284TriiodothyronineCHEMhas_chemical_structureliothyronine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
FDASPLN0000175946l-TriiodothyronineEPChas_epcliothyronine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine sodium
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD014284TriiodothyronineCHEMhas_ingredientliothyronine sodium
MEDRTD014284TriiodothyronineCHEMhas_ingredientliothyronine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withliothyronine sodium
MEDRTD000309Adrenal InsufficiencyDISEASEci_withliothyronine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withliothyronine sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withliothyronine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_treatliothyronine sodium
MEDRTD006042GoiterDISEASEmay_preventliothyronine
MEDRTD006042GoiterDISEASEmay_treatliothyronine
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_preventliothyronine sodium
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventliothyronine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventliothyronine
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatliothyronine sodium
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium
MEDRTD009230MyxedemaDISEASEmay_treatliothyronine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine sodium
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoseliothyronine sodium
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoseliothyronine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatliothyronine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatliothyronine
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatliothyronine
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatliothyronine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatliothyronine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withliothyronine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatliothyronine
MEDRTD013971ThyrotoxicosisDISEASEci_withliothyronine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moaliothyronine sodium
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moaliothyronine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_peliothyronine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_peliothyronine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_peliothyronine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_peliothyronine
MEDRTN0000009399Increased Metabolic RatePEhas_peliothyronine sodium
MEDRTN0000009399Increased Metabolic RatePEhas_peliothyronine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.025 MG / 0.00625 MG (expressed as liothyronine sodium)
ATTRIBUTESAVAILABLE_STRENGTH0.1 MG / 0.025 MG (expressed as liothyronine sodium)
ATTRIBUTESAVAILABLE_STRENGTH0.15 MG / 0.0375 MG (expressed as liothyronine sodium)
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESSNOMEDCT768535008
SOURCESSourceUS Edition of SNOMED_CT